We're #hiring a new Sales Manager/Director, North America in Greater Boston. Apply today or share this post with your network.
关于我们
SJLife Sciences are a Global Talent Partner that exclusively serves the Pharmaceutical, Biotechnology, Medical Device, and CRO sectors.
Our Mission is to provide a focused, quality-driven consultative offering that combines an exceptional market understanding of the Life Science industry with a dedication and passion to go above and beyond for our clients and candidates. We want to do more than just recruit the right people for the right role. We want to build partnerships that change people's lives.
We recognize the expanding and growing need for talent within the life sciences industry, which is why we have consultants dedicated to placing candidates with the right skills and experience across our European and US markets. Combined with our expertise and deep knowledge of the life sciences industry, we can become your lifelong partner in an exciting career.
Whether you’re potentially looking for a new opportunity or looking to attract talent to your team, we’d love to hear from you.
- 网站
-
https://sj-talentgroup.com/sj-life-partners/
SJLife Sciences的外部链接
- 所属行业
- 人才中介
- 规模
- 11-50 人
- 总部
- Greater Boston
- 类型
- 私人持股
- 创立
- 2023
- 领域
- life sciences、biotech、pharmaceutical、medical device、CRO、CDMO、Talent Acquisition和Executive Search
地点
SJLife Sciences员工
-
Jamie Stevenson
Founder / Director / Investor - Partnering with SME’s & Brands struggling to find your future stars, attracting top talent, and enhancing your brand…
-
Grant Smillie
?? Building neuroscience teams one hire at a time
-
Daniel Nation
Director at SJLife Sciences | Passionate about making a difference within the High Unmet Medical Need space ??
-
Archie Reaney
??Shaping Obesity Teams, One Strategic Hire At A Time
动态
-
?? Last weeks deep neuroscience dive for anyone who missed it
?? Following the recent Genentech news of Evrysdi comes another win from the biotech, this week in the form of TNKase? for the AIS community, the first new treatment approved by the FDA in close to 30 years - huge news. Plenty of other clinical news this week; regulatory, readouts and plans amongst real promise coming out of the State of Texas. If you don't have time to check out this newsletter then see the comments for this weeks quick-read snapshot.
-
?? Looking for a clinician, MD to run your Clinical Development programs within the neuro space? Check out some of the top talent Grant is working with below ??
?? With more companies solely focusing on programs in the clinic and less putting an onus on R&D, MD Clinicians/Neurologists with ClinDev industry experience are becoming more widely demanded and less widely available. That being said, here is some information about a few of the exceptional individuals I’m working with in this space: ?? ????????????: board certified neurologist, early phase has been their primary focus but experience within late phase as well. Heavy focus on AD with good industry experience to match but exposure to other indications too. Wants to remain East Coast but happy to travel regularly and open to contract or FTE ?? ??????????????????????: board certified neurologist, good Phase 1-3 experience within industry. Focus primarily on AD but some other neurodegenerative diseases as well. Willing to relocate (EU or US) for an FTE role but open to contract in the EU too ?? ??????????????: psychiatry board certified, Phase 1-2 expertise. Experience across a wide range of psychiatry indications. Open to relocating (EU or US) for an FTE role ?? ????????????: board certified neurologist and still runs own clinic 1 day per week. Sub-speciality in PD with 5 years industry experience across Phase 2-3. Open to relocating (EU or US) for FTE role ?? ?????? ????????: neurologist with deep industry experience across all phases. Speciality on ALS and FTA but exposure to other indications as well
-
-
This weeks deep dive into neuroscience from Grant below ????
?? Takeda continue their hot streak from an investment perspective with the rest of the week heavily dominated by companies completing dosing. More neuroscience news and more promise. If you don't have time to have a deep dive on this newsletter then see the comments for this weeks quick-read snapshot.
-
Do you consider picking a specialist who’s embedded in your therapeutic area when selecting your preferred recruitment partner? Take a Clinical Development MD Lead in Alzheimer’s as an example. It’s very possible for any headhunter to do a keyword search: “clinician”, “Medical Director”, “drug development”, “clinical development”, schedule a call with those who match the keywords and if they’re suitable, present that person/those people??... But headhunting is about more than that. Headhunting is knowing your industry inside and out; knowing each company, knowing a company's competitors, being connected with those people (and not just a LinkedIn connection but a genuine connection with those people) etc. And what about those people who haven’t even got a LinkedIn profile, or someone who could be perfect for the role, is ClinDev through and through but they’re missing “clinical development” on their LinkedIn so they don’t flag up on the keyword search. What about when it comes to screening those people? It’s easier to make an informed judgement when you know a person, know what they’re looking for, what type of environment they will match, what science they’re looking for etc. rather than just having a one, 30-minute Teams call with them and hoping it’s a match (??!) Sure, you might still get the role filled but you might be missing the best in class. What potential culture match have you missed out on that you might regret later down the line when you need to be hiring for the same position in 6-12 months? Of course, there’s more to consider than just picking someone in your TA area; reputation, personal chemistry/rapport, recruitment approach etc. but in my opinion it’s a great start point. That being said, if you’re interested in using/already looking for a dedicated neuroscience recruiter then reach out. Alternatively if you’re interested in keeping up to date with the latest industry news then check out my weekly newsletter on my profile ??
-
?? Get in touch! ??
Director at SJLife Sciences | Passionate about making a difference within the High Unmet Medical Need space ??
If you're passionate about the Organ-on-Chip space, I have two fantastic opportunities you won't want to miss. ? Senior Field Application Scientist based in Boston: If you have experience with microphysiological systems or lipid nanoparticle synthesis devices, let's talk! ? Sales Director (Remote): Seeking a dynamic individual to lead sales efforts within the Organ-on-Chip space. Want to explore these roles further? Drop me a message ?? ?? #OrganOnChip #JobOpportunity #LifeSciences
-
-
?? ?????? ?????????????? ???????????????? | ???? ????/????/???????? ?? ???????????????? ?????? ?????????????????????? ? Fractyl Health halts a diabetes trial to prioritise ???????????? for post ??????-?? weight management and advance ???????????? gene therapy. ? D&D Pharmatech has fully enrolled its phase II trial of ????????, a fast track dual ??????-??/???????????????? agonist for ????????. ? New peptides, ?????????? and ??????????, offer a weight loss alternative without the nausea of ??????????????. Trials are expected within a year, though experts remain cautious about side effects. ? Rani Therapeutics' ????????????????? HC delivered ?????????????????????? orally with results matching injections. A Phase 1 trial for ????-?????? starts in 2025. ? AgelessRx introduces sublingual ??????-?? drops to support metabolic health, obesity management, and longevity. ? Palatin Technologies has completed its Phase 2 study on ?????????bremelanotide combined with ??????-??/?????? ?????????????????????? for obesity. ?? ?????????????????? ? Vetigenics raised $6M to advance pet antibody therapies for obesity, cancer, autoimmune disease, and allergies. ? Terns Pharmaceuticals granted a new employee options for 250,000 shares at $4.46 per share under its 2022 Inducement Plan. ? Novo Nordisk’s Obesity care sales grew 56% in 2024, with ?????????????????? and ?????????????????????? showing significant weight loss in trials. ? Pfizer is targeting $15B deals, focusing on obesity and China, while awaiting data on its ??????-?? weight loss candidate, ??????????????????????. ? Amgen exceeded Q4 revenue estimates but faced setbacks with its obesity drug ?????? ??????. It projects 2025 revenues of $34.3B–$35.7B. ? ???????????? sales soared 107% to $2.77 billion, yet analysts push for more. Novo Nordisk holds over half the U.S. market and forecasts 16%-24% growth in 2025. ? Metsera closed its IPO, raising $316.2 million by offering 17.6 million shares at $18 each. ? ???????????????? sales hit $4.9B in its first year. CEO Dave Ricks defends expansion, projecting up to $61B in 2025 revenue while exploring oral obesity drugs. ?? ???????????????????????? ? VION Biosciences acquired BioAssay Systems, boosting its obesity and metabolic disorder research tools. This is VION's fourth acquisition. ?? ???????? ? Online pharmacies must verify patients beyond questionnaires for drugs like ????????????, aiming to curb misuse. ? Ivim Health warns the FDA's March 19 ban on compounded ?????????????????????? risks patient health and calls for a delay. ? The FDA classified VidaSlim Co. recall as Class 1 due to toxic yellow oleander, posing serious health risks.
-
-
We're #hiring a new Director/Snr Director of Global Pricing and Market Access in Boston, Massachusetts. Apply today or share this post with your network.
-
We're #hiring a new Director of Business Development in United States. Apply today or share this post with your network.
-
Filling leadership gaps swiftly can be a game-changer for your business. SJLife Sciences interim executive recruitment services are designed to support you during those crucial periods of change. We offer immediate access to a curated network of top industry professionals who are ready to step in and make an impact. ?
Director at SJLife Sciences | Passionate about making a difference within the High Unmet Medical Need space ??
?????????????? ?????????? ?????????????? ?????? ???????? ??????????-???????? ??????????????, ???????? ?? ?????????????? ????????????, ???? ???????? ???? ?????????? ?????? ?? ?????? ????????????????? ?? In today's fast-paced life sciences and healthcare industries, leadership gaps can emerge unexpectedly. Whether it's a sudden executive departure, a key player taking leave, scaling up for a new initiative, or delivering a crucial project on budget - these gaps can derail critical projects and stall growth. What's the solution? Finding the right interim leader quickly. ?? Here's why it's crucial: - ? Seamless Transition: Keep momentum going without a hitch. - ? Expertise On-Demand: Get specialised skills immediately. - ? Flexibility: Adapt to changing needs. - ? Cost-Effective: Avoid long-term payroll commitments. At SJLife Sciences, we've seen first-hand how a well-placed interim leader can turn potential crises into opportunities for growth and innovation. With our vast network and deep industry knowledge, we ensure you're matched with the right talent swiftly. Our approach isn't just about filling a position - it's about ensuring a seamless fit that drives your business forward. ? Extensive network of vetted professionals ? Leaders who align with your values and goals ? Bespoke, on-demand leadership solutions If you're facing a leadership gap, don't let it hold you back. Let's chat about how we can support your needs. Visit https://lnkd.in/eNK8N84Y or drop me a message below! #Leadership #Healthcare #LifeSciences
-